A new market from weight-loss drugs
GLP-1 drugs such as Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Zepbound help people lose weight by mimicking a hormone that creates a feeling of fullness. Besides gastrointestinal side effects, the rapid weight loss can lead to loose skin on the face and body.
Washington-based facial plastic surgeon Michael Somenek said he had seen a surge in treatment requests from GLP-1 patients over the past year. According to a 2024 Medical Insight report, 53 percent of US aesthetics clinics expect an influx of new patients due to prescription weight-loss drugs.
When you're looking at a large amount of weight loss over four to six months, that can really have impact on the volume within your face.
Companies race in
Galderma, 20 percent owned by L'Oréal, last year studied how some existing treatments, such as Sculptra, which stimulates natural collagen, and the filler Restylane, perform on skin changes linked to GLP-1 drugs. Although the treatments are not specifically approved for GLP-1 users, Galderma works with tens of thousands of aesthetic practitioners worldwide.

















